No clinically relevant differences were seen in the pharmacokinetics of repaglinide, when repaglinide was administered 0, 15 or 30 minutes before a meal or in fasting state.
No se observaron diferencias clínicamente relevantes en la farmacocinética de repaglinida, cuando ésta se administró 0, 15 ó 30 minutos antes de una comida o en ayunas.